Evaluation of a Fracture Liaison Service in the Osteoporosis Care

April 26, 2023 updated by: Groupe Hospitalier Paris Saint Joseph

The St JOSEPH'S HOSPITAL set up a fracture liaison service for osteopotic fracture. A specific nurse screens eligible patient admitted in emergency yard and call them to propose a bone densitometry and a medical coverage..

The aim of the study is to evaluate this new organisation

Study Overview

Status

Terminated

Study Type

Observational

Enrollment (Actual)

346

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ile-de-France
      • Paris, Ile-de-France, France, 75014
        • Groupe hospitalier Paris saint Joseph

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 95 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients admitted in emergency yard for low energy fracture

Description

Inclusion Criteria:

  • Age between 45 and 95 years old.
  • Admitted in emergency yard for law energy trauma

Exclusion Criteria:

  • feet fracture
  • fracture on prothesis
  • patient transferred elsewhere
  • homeless people
  • patient with lot of comorbidities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
valuable osteoporosis care
Time Frame: Month 1
valuable osteoporosis care means a bone densitometry for minor fracture and a medical treatment for major fracture
Month 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 8, 2018

Primary Completion (Actual)

August 7, 2018

Study Completion (Actual)

April 26, 2023

Study Registration Dates

First Submitted

March 25, 2018

First Submitted That Met QC Criteria

March 25, 2018

First Posted (Actual)

March 30, 2018

Study Record Updates

Last Update Posted (Actual)

April 28, 2023

Last Update Submitted That Met QC Criteria

April 26, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Osteoporotic Fractures

Clinical Trials on osteoporotic fracture liaison service

3
Subscribe